Hepatitis C in Egypt Omar Khalil and Justus

  • Slides: 12
Download presentation
Hepatitis C in Egypt Omar Khalil and Justus Sauckel

Hepatitis C in Egypt Omar Khalil and Justus Sauckel

Geography

Geography

Current Health Problems in Egypt Obesity Drug abuse rising Smoking Typhoid fever Hepatitis

Current Health Problems in Egypt Obesity Drug abuse rising Smoking Typhoid fever Hepatitis

Hepatits C Viral infectious disease (HCV) Spread by blood-to-blood contact In 75 -85% of

Hepatits C Viral infectious disease (HCV) Spread by blood-to-blood contact In 75 -85% of cases the virus persists in the liver Chronic liver disease may lead to cirrhosis and cancer

Contraction of Hep C Sharing needles Health care exposure Body modifications Sharing hygiene products

Contraction of Hep C Sharing needles Health care exposure Body modifications Sharing hygiene products Mother-to-child transmission

Prevalence of Hepatits C

Prevalence of Hepatits C

Prevalence in Egypt >14% of the population are infected Highest worldwide Hepatits C prevalence

Prevalence in Egypt >14% of the population are infected Highest worldwide Hepatits C prevalence Introduction by unsanitary treatment of schistosomiasis

Symptoms Initial infection shows little to no symptoms Acute symptoms only in 15% of

Symptoms Initial infection shows little to no symptoms Acute symptoms only in 15% of cases Decreased appetite, fatigue, nasuea Jaundice in rare cases

Progression of Hepatitis C

Progression of Hepatitis C

Treatment Resoloves spontaneously in 10 -15% Avoiding liver toxins Antiviral medications Liver transplantation 40

Treatment Resoloves spontaneously in 10 -15% Avoiding liver toxins Antiviral medications Liver transplantation 40 -80% success rate

Prevention Don‘t share sanitary products Use of sterile equipment in hospitals Don‘t share needles,

Prevention Don‘t share sanitary products Use of sterile equipment in hospitals Don‘t share needles, get your own

Sources https: //bmcinfectdis. biomedcentral. com/articles/10. 1186/147 1 -2334 -13 -288 http: //www. who. int/features/2014/egypt-campaignhepatitisc/en/

Sources https: //bmcinfectdis. biomedcentral. com/articles/10. 1186/147 1 -2334 -13 -288 http: //www. who. int/features/2014/egypt-campaignhepatitisc/en/ http: //www. healthline. com/health/hepatitis-c/stagesprogression#3 https: //www. ncbi. nlm. nih. gov/pubmed/16628669